BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sanal MG. Biomarkers in nonalcoholic fatty liver disease-the emperor has no clothes? World J Gastroenterol 2015; 21(11): 3223-3231 [PMID: 25805928 DOI: 10.3748/wjg.v21.i11.3223]
URL: https://www.wjgnet.com/1007-9327/full/v21/i11/3223.htm
Number Citing Articles
1
Moein Askarpour, Kurosh Djafarian, Ehsan Ghaedi, Omid Sadeghi, Ali Sheikhi, Sakineh Shab-Bidar. Effect of L-Carnitine Supplementation on Liver Enzymes: A Systematic Review and Meta-analysis of Randomized Controlled TrialsArchives of Medical Research 2020; 51(1): 82 doi: 10.1016/j.arcmed.2019.12.005
2
Irene Cantero, Itziar Abete, Josep Maria del Bas, Antoni Caimari, Lluís Arola, M. Angeles Zulet, J. Alfredo Martinez. Changes in lysophospholipids and liver status after weight loss: the RESMENA studyNutrition & Metabolism 2018; 15(1) doi: 10.1186/s12986-018-0288-5
3
Madhusudana Girija Sanal. Is the change from NAFLD to MASLD driven by political correctness?Journal of Hepatology 2024; 80(2): e74 doi: 10.1016/j.jhep.2023.08.027
4
Pedro Paulo Caravatto, Ricardo Cohen. The Role of Metabolic Surgery in Non-alcoholic Steatohepatitis ImprovementCurrent Atherosclerosis Reports 2017; 19(11) doi: 10.1007/s11883-017-0681-y
5
Mabel Graffigna, Natalia Catoira, Jimena Soutelo, Andreína Azpelicueta, Gabriela Berg, Cecilia Perel, Marta Elena Migliano, Marcela Aranguren, Carla Musso, Javier Farias. Diagnóstico de esteatosis hepática por métodos clínicos, bioquímicos y por imágenesRevista Argentina de Endocrinología y Metabolismo 2017; 54(1): 37 doi: 10.1016/j.raem.2016.12.001
6
Brandon J Perumpail, Muhammad Ali Khan, Eric R Yoo, George Cholankeril, Donghee Kim, Aijaz Ahmed. Clinical epidemiology and disease burden of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2017; 23(47): 8263-8276 doi: 10.3748/wjg.v23.i47.8263
7
E.P.S. Conceição, E.G. Moura, P.N. Soares, X.X. Ai, M.S. Figueiredo, E. Oliveira, P.C. Lisboa. High calcium diet improves the liver oxidative stress and microsteatosis in adult obese rats that were overfed during lactationFood and Chemical Toxicology 2016; 92: 245 doi: 10.1016/j.fct.2016.04.015
8
Long Wang, Jinghui Guo, Jianping Lu. Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and femalesOncotarget 2016; 7(24): 35632 doi: 10.18632/oncotarget.9691
9
E. P. S. Conceição, E. G. Moura, J. C. Carvalho, E. Oliveira, P. C. Lisboa. Early redox imbalance is associated with liver dysfunction at weaning in overfed ratsThe Journal of Physiology 2015; 593(21): 4799 doi: 10.1113/JP271189
10
Elena V. Vinnitskaya, Yuliay G. Sandler, Kirill G. Saliev, Anton N. Ivanov, Evgenia S. Sbikina, Tatyana Yu. Khaymenova, Dmitry S. Bordin. Efficacy of human placenta hydrolyzate in the treatment of patients with metabolic associated fatty liver disease at the stage of fibrosis (pilot study)Terapevticheskii arkhiv 2024; 96(2): 107 doi: 10.26442/00403660.2024.02.202582
11
Irene Cantero, Itziar Abete, Nancy Babio, Fernando Arós, Dolores Corella, Ramón Estruch, Montse Fitó, James R. Hebert, M. Ángel Martínez-González, Xavier Pintó, M. Puy Portillo, Miguel Ruiz-Canela, Nitin Shivappa, Julia Wärnberg, Enrique Gómez-Gracia, J. Antoni Tur, Jordi Salas-Salvadó, M. Angeles Zulet, J. Alfredo Martínez. Dietary Inflammatory Index and liver status in subjects with different adiposity levels within the PREDIMED trialClinical Nutrition 2018; 37(5): 1736 doi: 10.1016/j.clnu.2017.06.027
12
Chieh-Chen Wu, Wen-Chun Yeh, Wen-Ding Hsu, Md. Mohaimenul Islam, Phung Anh (Alex) Nguyen, Tahmina Nasrin Poly, Yao-Chin Wang, Hsuan-Chia Yang, Yu-Chuan (Jack) Li. Prediction of fatty liver disease using machine learning algorithmsComputer Methods and Programs in Biomedicine 2019; 170: 23 doi: 10.1016/j.cmpb.2018.12.032
13
Aijaz Ahmed, Robert J. Wong, Stephen A. Harrison. Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and OutcomesClinical Gastroenterology and Hepatology 2015; 13(12): 2062 doi: 10.1016/j.cgh.2015.07.029
14
Nancy de los Ángeles Segura-Azuara, Carlos Daniel Varela-Chinchilla, Plinio A. Trinidad-Calderón. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis DiagnosisFrontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.774079
15
Nikhil S. Bhandarkar, Lindsay Brown, Sunil K. Panchal. Chlorogenic acid attenuates high-carbohydrate, high-fat diet–induced cardiovascular, liver, and metabolic changes in ratsNutrition Research 2019; 62: 78 doi: 10.1016/j.nutres.2018.11.002
16
Ming-Ling Chang, Jing-Hong Hu, Ching-Hao Yen, Kuan-Hsing Chen, Chia-Jung Kuo, Ming-Shyan Lin, Cheng-Han Lee, Shiang-Chi Chen, Rong-Nan Chien. Evolution of ferritin levels in hepatitis C patients treated with antiviralsScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-76871-z
17
Eugenia Tsai, Tai-Ping Lee. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient ElastographyClinics in Liver Disease 2018; 22(1): 73 doi: 10.1016/j.cld.2017.08.004
18
Riki Toita, Jeong-Hun Kang. Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver diseaseToxicology Letters 2020; 332: 1 doi: 10.1016/j.toxlet.2020.06.020
19
Chutima Leelalertlauw, Manassawee Korwutthikulrangsri, Pat Mahachoklertwattana, Suwannee Chanprasertyothin, Patcharin Khlairit, Sarunyu Pongratanakul, Preamrudee Poomthavorn. Serum glypican 4 level in obese children and its relation to degree of obesityClinical Endocrinology 2017; 87(6): 689 doi: 10.1111/cen.13435
20
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver DisorderCurrent Drug Therapy 2024; 19(1): 20 doi: 10.2174/1574885518666230417111247
21
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
22
Somaya Albhaisi, Arun J. Sanyal. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to DatePharmaceutical Medicine 2019; 33(6): 451 doi: 10.1007/s40290-019-00305-z
23
Mitsutaka Kohno, Hideo Sugano, Yuhko Shigihara, Yoshiaki Shiraishi, Takayasu Motoyama. Improvement of glucose and lipid metabolism via mung bean protein consumption: clinical trials of GLUCODIA™ isolated mung bean protein in the USA and CanadaJournal of Nutritional Science 2018; 7 doi: 10.1017/jns.2017.68
24
Mah I Kan Changez, Maryam Mubeen, Monezahe Zehra, Inara Samnani, Aniqa Abdul Rasool, Anmol Mohan, Um Ul Wara, Usha Tejwaney, Vikash Kumar. Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive reviewJournal of International Medical Research 2023; 51(9) doi: 10.1177/03000605231197058
25
D A Zhaldak, O K Melekhovets, V F Orlovskyi. CYP7A1 gene polymorphism and the characteristics of dyslipidemias in patients with nonalcoholic fatty liver disease concurrent with hypothyroidismTerapevticheskii arkhiv 2017; 89(10): 62 doi: 10.17116/terarkh2017891062-65
26
Filiz Fusun Bolukbas, Seyda İgnak, Ozlem Unay Demirel, Yavuz Furuncuoglu, Ferhan Mantar, Sercen Cansu Sertel, Filiz Yarimcan Saglam, Cengiz Bolukbas. Alkole bağlı olmayan karaciğer yağlanmasında transient elastografi (Fibroscan) tekniği ile tespit edilen fibrozis skoru ile serum Vitamin B12 arasındaki ilişkinin araştırılmasıAnadolu Kliniği Tıp Bilimleri Dergisi 2017;  doi: 10.21673/anadoluklin.297152
27
Stephen A. Harrison, Salvatore Calanna, Kenneth Cusi, Martin Linder, Takeshi Okanoue, Vlad Ratziu, Arun Sanyal, Anne-Sophie Sejling, Philip N. Newsome. Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkersContemporary Clinical Trials 2020; 97: 106174 doi: 10.1016/j.cct.2020.106174
28
Prajith Raj Ramesh, Priya Krishnan, Samyuktha Prabu, Varshini Srinivasan, Varalakshmi Niranjan. Diagnosis and management of metabolic dysfunction- associated steatotic liver disease in South Asians- A clinical reviewObesity Pillars 2024; 12: 100142 doi: 10.1016/j.obpill.2024.100142
29
Joost Boeckmans, Alessandra Natale, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim M. Rodrigues. Human-based systems: Mechanistic NASH modelling just around the corner?Pharmacological Research 2018; 134: 257 doi: 10.1016/j.phrs.2018.06.029
30
Victoria Higgins, Arghavan Omidi, Houman Tahmasebi, Shervin Asgari, Kian Gordanifar, Michelle Nieuwesteeg, Khosrow Adeli. Marked Influence of Adiposity on Laboratory Biomarkers in a Healthy Cohort of Children and AdolescentsThe Journal of Clinical Endocrinology & Metabolism 2020; 105(4): e1781 doi: 10.1210/clinem/dgz161
31
Dachuan Jin, Zhongfeng Cui, Shunqin Jin, Tao Zhou, Baoqiang Guo, Peng Gao, Guangming Li. Comparison of efficacy of anti-diabetics on non-diabetic NAFLD: A network meta-analysisFrontiers in Pharmacology 2023; 13 doi: 10.3389/fphar.2022.1096064
32
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLDInternational Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570